Today, Mesothelioma Hub Remembers Inez St. John

Each year on September 26th, the medical community observes Mesothelioma Awareness Day. This year, Mesothelioma Hub remembers Inez St. John.

In August, the Centers for Medicare & Medicaid Services (CMS) approved the use of CAR T-cell therapy in patients with two specific cancers.

The results of a recent Phase 3 clinical trial have led to a disappointing setback for the mesothelioma community.

Emergency responders, health care professionals, and recovery workers injured on September 11th now have medical compensation for the next 70 years. President Donald Trump signed the 9/11 Victim Compensation Fund (VCF) bill into law during a ceremony on Monday at the White House Rose Garden. Members of the Senate approved the bill just last week. … Continued

In March of this year, the Food and Drug Administration (FDA) released a report citing its concern over asbestos-contaminated cosmetics.

The latest treatment for mesothelioma patients combines the power of electric currents with platinum-based chemotherapy drugs.

There is no conclusive research to prove herbal medicine alone can cure cancer. However, there are benefits to consuming botanicals, or substances derived from plants, in daily meals.

An new Phase 1 clinical trial using chimeric antigen receptor (CAR) T-cell therapy to attack pleural mesothelioma tumors shows promise for cancer patients.

A new type of immunogene therapy, also called virotherapy, is the subject of a Phase 3 clinical trial for patients diagnosed with pleural mesothelioma.

Once the law goes into effect, any individual caught selling, buying, or distributing products containing asbestos will face a $2,500 fine.